| 1 |
Zhukova EM, Kulchavenya EV. Efcacy and safety of combination therapy with bedaquiline in a multimorbid HIV positive patient with multiple drug resistant tuberculosis. Tuberk bolezni lëgk 2022;100:53-58. [DOI: 10.21292/2075-1230-2022-100-6-53-58] [Reference Citation Analysis]
|
| 2 |
Kebede F, Tarekegn H, Molla M, Jara D, Abate A, Wang M. Incidence and Predictors of Pulmonary Tuberculosis among Children Who Received Antiretroviral Therapy (ART), Northwest Ethiopia: A Multicenter Historical Cohorts Study 2009–2019. Journal of Tropical Medicine 2022;2022:1-9. [DOI: 10.1155/2022/9925693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Occhineri S, Matucci T, Rindi L, Tiseo G, Falcone M, Riccardi N, Besozzi G. Pretomanid for tuberculosis treatment: an update for clinical purposes. Curr Res Pharmacol Drug Discov 2022;3:100128. [PMID: 36105740 DOI: 10.1016/j.crphar.2022.100128] [Reference Citation Analysis]
|
| 4 |
Kebede F, Kebede T, Kebede B, Abate A, Jara D, Negese B, Shaweno T. Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy. Tuberc Res Treat 2021;2021:6686019. [PMID: 34812290 DOI: 10.1155/2021/6686019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Kebede F, Kebede B, Kebede T, Agmasu M. Effect of Isoniazid Preventive Therapy on the Incidence of Tuberculosis among Seropositive Children Attending HIV/AIDS Care in Two General Hospitals, Northwest Ethiopia, 2021. J Trop Med 2021;2021:9996953. [PMID: 34545289 DOI: 10.1155/2021/9996953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 6 |
Elvira D. Association of Urinary Interferon Gamma Protein-10 Levels and Low Levels of Cluster of Differentiation 4 Serum in Patients with Tuberculosis-Human Immunodeficiency Virus Coinfection. Open Access Maced J Med Sci 2021;9:707-710. [DOI: 10.3889/oamjms.2021.6661] [Reference Citation Analysis]
|
| 7 |
Masterova IY, Degtyareva SY, Narkevich AN, Shlykova LA, Zaitseva EV, Gavrilov PV. Valuation of Cavities in the Lungs Among HIV/TB Patients. jour 2021. [DOI: 10.52560/2713-0118-2021-4-22-33] [Reference Citation Analysis]
|
| 8 |
Kosgei RJ, Callens S, Gichangi P, Temmerman M, Kihara AB, David G, Omesa EN, Masini E, Carter EJ. Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya. PLoS One 2020;15:e0243977. [PMID: 33315954 DOI: 10.1371/journal.pone.0243977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Mehta S, Peters RP, Smit DP, Gupta V. Ocular Tuberculosis in HIV-infected Individuals. Ocul Immunol Inflamm 2020;28:1251-8. [PMID: 32809898 DOI: 10.1080/09273948.2020.1776882] [Reference Citation Analysis]
|
| 10 |
Wong K, Nguyen J, Blair L, Banjanin M, Grewal B, Bowman S, Boyd H, Gerstner G, Cho HJ, Panfilov D, Tam CK, Aguilar D, Venketaraman V. Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection. J Clin Med 2020;9:E3575. [PMID: 33172001 DOI: 10.3390/jcm9113575] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 11 |
Quinn CM, Poplin V, Kasibante J, Yuquimpo K, Gakuru J, Cresswell FV, Bahr NC. Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease. Life (Basel) 2020;10:E262. [PMID: 33138069 DOI: 10.3390/life10110262] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 12 |
Danilova TI, Korneev YV, Kudlay DA, Nikolenko NY. Results of treatment with bedaquiline containing regimens of MDR/XDR tuberculosis patients including those with concurrent HIV infection (the experience of Leningrad Region). Tuberk bolezni lëgk 2020;98:56-62. [DOI: 10.21292/2075-1230-2020-98-9-56-62] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 13 |
Moreno S, Perno CF, Mallon PW, Behrens G, Corbeau P, Routy JP, Darcis G. Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch? HIV Med 2019;20 Suppl 4:2-12. [PMID: 30821898 DOI: 10.1111/hiv.12716] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 14 |
Proud Tembo NF, Bwalya Muma J, Hang'ombe B, Munyeme M. Clustering and spatial heterogeneity of bovine tuberculosis at the livestock/wildlife interface areas in Namwala District of Zambia. Vet World 2020;13:478-88. [PMID: 32367953 DOI: 10.14202/vetworld.2020.478-488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 15 |
Reis AJ, Diniz JLCG, Silva ABS, Silveira J, Basso R, Vieira R, von Groll A, Ramis IB, da Silva PEA. Laboratory tools for tuberculosis control in a setting with a high burden of HIV/AIDS. J Med Microbiol 2019;68:1622-8. [PMID: 31596198 DOI: 10.1099/jmm.0.001089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 16 |
Zürcher K, Ballif M, Fenner L, Borrell S, Keller PM, Gnokoro J, Marcy O, Yotebieng M, Diero L, Carter EJ, Rockwood N, Wilkinson RJ, Cox H, Ezati N, Abimiku AG, Collantes J, Avihingsanon A, Kawkitinarong K, Reinhard M, Hömke R, Huebner R, Gagneux S, Böttger EC, Egger M; International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infect Dis 2019;19:298-307. [PMID: 30744962 DOI: 10.1016/S1473-3099(18)30673-X] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 17 |
Zürcher K, Ballif M, Fenner L, Borrell S, Keller PM, Gnokoro J, Marcy O, Yotebieng M, Diero L, Carter EJ, Rockwood N, Wilkinson RJ, Cox H, Ezati N, Abimiku AG, Collantes J, Avihingsanon A, Kawkitinarong K, Reinhard M, Hömke R, Huebner R, Gagneux S, Böttger EC, Egger M, on behalf of the International Epidemiology Databases to Evaluate AIDS (IeDEA). Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries.. [DOI: 10.1101/370056] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 18 |
Oliveira PR, Schibelbain AF, Neiva EG, Zarbin AJ, Marcolino- LH, Bergamini MF. Nickel hexacyanoferrate supported at nickel nanoparticles for voltammetric determination of rifampicin. Sensors and Actuators B: Chemical 2018;260:816-23. [DOI: 10.1016/j.snb.2017.12.198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 19 |
Schaaf HS, Garcia-prats AJ, Mckenna L, Seddon JA. Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children. Expert Review of Clinical Pharmacology 2018;11:233-44. [DOI: 10.1080/17512433.2018.1421067] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 20 |
Igarashi M, Ishizaki Y, Takahashi Y. New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development. J Antibiot (Tokyo) 2017. [PMID: 29089593 DOI: 10.1038/ja.2017.126] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 21 |
Beiranvand E, Abediankenari S, Valiyari S, Rezaei MS, Rostamian M, Beiranvand B, Khaligh A, Khani S. Single nucleotide polymorphisms of IFNγ (+874 A/T) and IFNγR1 (-56 C/T) in Iranian patients with TB. Trans R Soc Trop Med Hyg 2016;110:604-9. [PMID: 27941164 DOI: 10.1093/trstmh/trw074] [Reference Citation Analysis]
|
